Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation (Q40604741)

22 September 2017

Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation (English)

1 reference

22 September 2017

0 references

1 reference

Maho Koyama

1

1 reference

22 September 2017

Takashi Oka

2

1 reference

22 September 2017

Mamoru Ouchida

3

1 reference

22 September 2017

Yoko Nakatani

4

1 reference

22 September 2017

Ritsuo Nishiuchi

5

1 reference

22 September 2017

Tadashi Yoshino

6

1 reference

22 September 2017

Kazuhiko Hayashi

7

1 reference

22 September 2017

Tadaatsu Akagi

8

1 reference

22 September 2017

Yoshiki Seino

9

1 reference

22 September 2017

1 December 2003

1 reference

22 September 2017

Laboratory Investigation

1 reference

22 September 2017

83

1 reference

22 September 2017

12

1 reference

22 September 2017

1849-1858

1 reference

https://scigraph.springernature.com/pub.10.1097/01.lab.0000106503.65258.2b

22 September 2017

0 references

cites work

Epigenomics and epigenetic therapy of cancer

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Histone modification: the 'next wave' in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Mutagenicity of 5-aza-2'-deoxycytidine is mediated by the mammalian DNA methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000106503.65258.2B

10.1097/01.LAB.0000106503.65258.2B

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

22 September 2017

1012557211

0 references

Fatcat ID

release_4gmui44tpff3pbz2xi2kklgvem

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4gmui44tpff3pbz2xi2kklgvem

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference